Cargando…

Gene expression profiles in skeletal muscle after gene electrotransfer

BACKGROUND: Gene transfer by electroporation (DNA electrotransfer) to muscle results in high level long term transgenic expression, showing great promise for treatment of e.g. protein deficiency syndromes. However little is known about the effects of DNA electrotransfer on muscle fibres. We have the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hojman, Pernille, Zibert, John R, Gissel, Hanne, Eriksen, Jens, Gehl, Julie
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1925113/
https://www.ncbi.nlm.nih.gov/pubmed/17598924
http://dx.doi.org/10.1186/1471-2199-8-56
_version_ 1782134238852677632
author Hojman, Pernille
Zibert, John R
Gissel, Hanne
Eriksen, Jens
Gehl, Julie
author_facet Hojman, Pernille
Zibert, John R
Gissel, Hanne
Eriksen, Jens
Gehl, Julie
author_sort Hojman, Pernille
collection PubMed
description BACKGROUND: Gene transfer by electroporation (DNA electrotransfer) to muscle results in high level long term transgenic expression, showing great promise for treatment of e.g. protein deficiency syndromes. However little is known about the effects of DNA electrotransfer on muscle fibres. We have therefore investigated transcriptional changes through gene expression profile analyses, morphological changes by histological analysis, and physiological changes by force generation measurements. DNA electrotransfer was obtained using a combination of a short high voltage pulse (HV, 1000 V/cm, 100 μs) followed by a long low voltage pulse (LV, 100 V/cm, 400 ms); a pulse combination optimised for efficient and safe gene transfer. Muscles were transfected with green fluorescent protein (GFP) and excised at 4 hours, 48 hours or 3 weeks after treatment. RESULTS: Differentially expressed genes were investigated by microarray analysis, and descriptive statistics were performed to evaluate the effects of 1) electroporation, 2) DNA injection, and 3) time after treatment. The biological significance of the results was assessed by gene annotation and supervised cluster analysis. Generally, electroporation caused down-regulation of structural proteins e.g. sarcospan and catalytic enzymes. Injection of DNA induced down-regulation of intracellular transport proteins e.g. sentrin. The effects on muscle fibres were transient as the expression profiles 3 weeks after treatment were closely related with the control muscles. Most interestingly, no changes in the expression of proteins involved in inflammatory responses or muscle regeneration was detected, indicating limited muscle damage and regeneration. Histological analysis revealed structural changes with loss of cell integrity and striation pattern in some fibres after DNA+HV+LV treatment, while HV+LV pulses alone showed preservation of cell integrity. No difference in the force generation capacity was observed in the muscles 2 weeks after DNA electrotransfer. CONCLUSION: The small and transient changes found in the gene expression profiles are of great importance, as this demonstrates that DNA electrotransfer is safe with minor effects on the muscle host cells. These findings are essential for introducing the DNA electrotransfer to muscle for clinical use. Indeed the HV+LV pulse combination used has been optimised to ensure highly efficient and safe DNA electrotransfer.
format Text
id pubmed-1925113
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19251132007-07-20 Gene expression profiles in skeletal muscle after gene electrotransfer Hojman, Pernille Zibert, John R Gissel, Hanne Eriksen, Jens Gehl, Julie BMC Mol Biol Research Article BACKGROUND: Gene transfer by electroporation (DNA electrotransfer) to muscle results in high level long term transgenic expression, showing great promise for treatment of e.g. protein deficiency syndromes. However little is known about the effects of DNA electrotransfer on muscle fibres. We have therefore investigated transcriptional changes through gene expression profile analyses, morphological changes by histological analysis, and physiological changes by force generation measurements. DNA electrotransfer was obtained using a combination of a short high voltage pulse (HV, 1000 V/cm, 100 μs) followed by a long low voltage pulse (LV, 100 V/cm, 400 ms); a pulse combination optimised for efficient and safe gene transfer. Muscles were transfected with green fluorescent protein (GFP) and excised at 4 hours, 48 hours or 3 weeks after treatment. RESULTS: Differentially expressed genes were investigated by microarray analysis, and descriptive statistics were performed to evaluate the effects of 1) electroporation, 2) DNA injection, and 3) time after treatment. The biological significance of the results was assessed by gene annotation and supervised cluster analysis. Generally, electroporation caused down-regulation of structural proteins e.g. sarcospan and catalytic enzymes. Injection of DNA induced down-regulation of intracellular transport proteins e.g. sentrin. The effects on muscle fibres were transient as the expression profiles 3 weeks after treatment were closely related with the control muscles. Most interestingly, no changes in the expression of proteins involved in inflammatory responses or muscle regeneration was detected, indicating limited muscle damage and regeneration. Histological analysis revealed structural changes with loss of cell integrity and striation pattern in some fibres after DNA+HV+LV treatment, while HV+LV pulses alone showed preservation of cell integrity. No difference in the force generation capacity was observed in the muscles 2 weeks after DNA electrotransfer. CONCLUSION: The small and transient changes found in the gene expression profiles are of great importance, as this demonstrates that DNA electrotransfer is safe with minor effects on the muscle host cells. These findings are essential for introducing the DNA electrotransfer to muscle for clinical use. Indeed the HV+LV pulse combination used has been optimised to ensure highly efficient and safe DNA electrotransfer. BioMed Central 2007-06-29 /pmc/articles/PMC1925113/ /pubmed/17598924 http://dx.doi.org/10.1186/1471-2199-8-56 Text en Copyright © 2007 Hojman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hojman, Pernille
Zibert, John R
Gissel, Hanne
Eriksen, Jens
Gehl, Julie
Gene expression profiles in skeletal muscle after gene electrotransfer
title Gene expression profiles in skeletal muscle after gene electrotransfer
title_full Gene expression profiles in skeletal muscle after gene electrotransfer
title_fullStr Gene expression profiles in skeletal muscle after gene electrotransfer
title_full_unstemmed Gene expression profiles in skeletal muscle after gene electrotransfer
title_short Gene expression profiles in skeletal muscle after gene electrotransfer
title_sort gene expression profiles in skeletal muscle after gene electrotransfer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1925113/
https://www.ncbi.nlm.nih.gov/pubmed/17598924
http://dx.doi.org/10.1186/1471-2199-8-56
work_keys_str_mv AT hojmanpernille geneexpressionprofilesinskeletalmuscleaftergeneelectrotransfer
AT zibertjohnr geneexpressionprofilesinskeletalmuscleaftergeneelectrotransfer
AT gisselhanne geneexpressionprofilesinskeletalmuscleaftergeneelectrotransfer
AT eriksenjens geneexpressionprofilesinskeletalmuscleaftergeneelectrotransfer
AT gehljulie geneexpressionprofilesinskeletalmuscleaftergeneelectrotransfer